GATC HEALTH CORP
OperatingHealthcare · Irvine, CA
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
“Today's shares” restates every price in the share terms current now, so a price before a split or an LLC→corporation conversion is divided by that event's ratio (each event is cited on the round page). Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Dec 31, 2024| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 71,504,031 | 1 | 100.0% | $5.00Aug 2024 |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Eugene O'Bryan69K (0.1%) Nov 2025 → 400K Mar 2026
- Gerry Martin16M (48.8%) Jul 2021 → 7.4M (45.3%) Sep 2021 → 371K (0.86%) May 2022 → 6.9M (9.59%) Oct 2024
- Ian Jenkins120M (365.9%) Jul 2021 → 60M (365.9%) Sep 2021 → 3.0M (6.95%) May 2022 → 6.7M (9.31%) Oct 2024
- Jayson Uffens120M (365.9%) Jul 2021 → 60M (365.9%) Sep 2021 → 3.0M (6.95%) May 2022 → 6.7M (9.31%) Oct 2024 → 6.6M Mar 2026
- Jeff Moses2.4M (3.37%) Oct 2024 → 2.4M Mar 2026
- John Stroh100K (0.14%) Oct 2024 → 66K Mar 2026
- Phillip Trad0 (0%) Oct 2024 → 110K Mar 2026
- Sakura Tran12M (36.6%) Jul 2021 → 6.0M (36.6%) Sep 2021 → 282K (0.65%) May 2022 → 5.6M (7.89%) Oct 2024
- Ty Lam67K (0.09%) Oct 2024 → 92K Mar 2026
Principal holders% as the filing states it, Mar 13, 2026
- Jayson Uffens6,633,420 Common Stock14.3%of
- Ian Jenkins6,658,420 Common Stock14.3%of
- Gerry Martin6,858,977 Common Stock11.9%of
- Sakura Tran5,638,667 Common Stock10.1%of
- Jeff Moses2,399,614 Common Stock3.7%of
- Ty Lam91,654 Common Stock3%of
- Dennis Locke2,363,566 Common Stock2.8%of
- Eugene O'Bryan399,993 Common Stock0.8%of
- Dr. Rahul Gupta0 Common Stock0.6%of
- Lin Yu0 Common Stock0.5%of
- Phillip Trad110,000 Common Stock0.5%of
- Gerald DeCiccio0 Common Stock0.2%of
- John Stroh65,500 Common Stock0.1%of
- Uri Litvak100,000 Common Stock—of votes
- Bob Davidson1,675,000 Common Stock—of votes
Sold to the crowd
- Reg A+ · Jul 2021151,200 shares at $0.125 in today's terms · sold as 3,780 shares at $5.00; since then a 2-for-1 split (Aug 2021), each unit became 20 shares (Dec 2021), a 1-for-1 split (Jun 2023)$18.9K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
6 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 41 filings on EDGAR- Form 1-SAApr 10, 20260001096906-26-000524EDGAR
- Form 1-UApr 10, 20260001096906-26-000522EDGAR
- Form 1-KMar 13, 20260001096906-26-000302EDGAR
- Form 1-SAMar 12, 20260001096906-26-000295EDGAR
- Form 1-KNov 28, 20250001096906-25-001945EDGAR
- Form D/ASep 15, 20250001822995-25-000002EDGAR
- Form 1-UJun 10, 20250001096906-25-000942EDGAR
- Form 1-UMay 8, 20250001096906-25-000716EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.